Aytu Biopharma (AYTU) Net Cash Flow Growth (5y) (2019 - 2025)
Aytu Biopharma (AYTU) Net Cash Flow Growth (5y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.69 Bn | 87.82 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.60 Bn | 30.66 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.53 Bn | 23.47 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.06 Bn | 20.91 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - |
| 7 | Viatris | 20.32 Bn | 18.52 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.47 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Aytu Biopharma | 21.97 Mn | -4.75 Mn | 7.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -16.08% |
| Sep 30, 2025 | 16.70% |
| Jun 30, 2025 | 23.73% |
| Mar 31, 2025 | -15.16% |
| Dec 31, 2024 | 16.71% |
| Sep 30, 2024 | 15.16% |
| Jun 30, 2024 | 15.68% |
| Mar 31, 2024 | 15.70% |
| Dec 31, 2023 | -15.23% |
| Sep 30, 2023 | 0.18% |
| Jun 30, 2023 | 22.58% |
| Mar 31, 2023 | -15.33% |
| Dec 31, 2022 | -7.04% |
| Sep 30, 2022 | -6.27% |
| Jun 30, 2022 | -25.34% |
| Mar 31, 2022 | -34.21% |
| Dec 31, 2021 | -32.77% |
| Sep 30, 2021 | -12.32% |
| Jun 30, 2021 | 47.78% |
| Dec 31, 2020 | 93.47% |